These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 4383882)

  • 1. Relationship between the contents of virus neutralizing inhibitors and cofactor in the blood and the course of experimental vaccinia infection in rabbits.
    Shuratov IK; Yabrov AA; Smorodintsev AA
    Acta Virol; 1967 Nov; 11(6):485-93. PubMed ID: 4383882
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of lysozyme and character of antibodies in experimental viral infection.
    Mĕstecký J; Medlín J
    Acta Virol; 1967 May; 11(3):206-15. PubMed ID: 4382473
    [No Abstract]   [Full Text] [Related]  

  • 3. [Relation between antibody formation and immunity against cutaneous vaccinia virus infection in hens].
    Andrzejewski J; Bogunowicz A; Zajac I
    Zentralbl Bakteriol Orig; 1968; 207(3):419-21. PubMed ID: 5745681
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibodies to the A27 protein of vaccinia virus neutralize and protect against infection but represent a minor component of Dryvax vaccine--induced immunity.
    He Y; Manischewitz J; Meseda CA; Merchlinsky M; Vassell RA; Sirota L; Berkower I; Golding H; Weiss CD
    J Infect Dis; 2007 Oct; 196(7):1026-32. PubMed ID: 17763325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of interferon in protection of rabbits against rinderpest virus.
    Fujisaki Y; Ishii S; Watanabe M
    Natl Inst Anim Health Q (Tokyo); 1968; 8(3):122-31. PubMed ID: 5712545
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of a cofactor on the sensitivity of the vaccinia virus neutralization reaction in tissue culture].
    Piskareva NA; Gaeva LL
    Lab Delo; 1971; 12():733-6. PubMed ID: 4111447
    [No Abstract]   [Full Text] [Related]  

  • 7. [An unusual infection with the vaccinia virus (poxvirus officinale)].
    Kirsch WD; Handrick W; Keller HP
    Dtsch Med Wochenschr; 1973 Jun; 98(26):1292-4. PubMed ID: 4714029
    [No Abstract]   [Full Text] [Related]  

  • 8. Extracellular enveloped vaccinia virus escapes neutralization.
    Ichihashi Y
    Virology; 1996 Mar; 217(2):478-85. PubMed ID: 8610439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experiences with improvement of the neutralization reaction with vaccinia virus in chick fibroblast cultures.
    Aksenov OA; Smorodintsev AA
    J Hyg Epidemiol Microbiol Immunol; 1966; 10(4):488-98. PubMed ID: 6006816
    [No Abstract]   [Full Text] [Related]  

  • 10. Experimental swinepox in gnotobiotic piglets.
    Meyer RC; Conroy JD
    Res Vet Sci; 1972 Jul; 13(4):334-8. PubMed ID: 4342074
    [No Abstract]   [Full Text] [Related]  

  • 11. Neutralizing and protective antibodies directed against vaccinia virus envelope antigens.
    Galmiche MC; Goenaga J; Wittek R; Rindisbacher L
    Virology; 1999 Feb; 254(1):71-80. PubMed ID: 9927575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formation and persistence of neutralizing, complement-fixing and haemagglutination-inhibiting antibodies in Tahyna virus experimental infection of rabbits.
    Málková D; Kolman JM; Marhoul Z
    J Hyg Epidemiol Microbiol Immunol; 1969; 13(4):482-92. PubMed ID: 5391989
    [No Abstract]   [Full Text] [Related]  

  • 13. Antibody in tears following intranasal vaccination with inactivated virus. 3. Role of tear and serum antibody in experimental vaccinia conjunctivitis.
    Knopf HL; Blacklow NR; Glassman MI; Cline WL; Wong VG
    Invest Ophthalmol; 1971 Oct; 10(10):760-9. PubMed ID: 4941860
    [No Abstract]   [Full Text] [Related]  

  • 14. Development of a tissue-culture-based enzyme-immunoassay method for the quantitation of anti-vaccinia-neutralizing antibodies in human sera.
    Eyal O; Olshevsky U; Lustig S; Paran N; Halevy M; Schneider P; Zomber G; Fuchs P
    J Virol Methods; 2005 Dec; 130(1-2):15-21. PubMed ID: 16024096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy and repeatability of a micro plaque reduction neutralization test for vaccinia antibodies.
    Borges MB; Kato SE; Damaso CR; Moussatché N; da Silva Freire M; Lambert Passos SR; do Nascimento JP
    Biologicals; 2008 Mar; 36(2):105-10. PubMed ID: 17892944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversed passive haemagglutination-inhibition method for the estimation of antivaccinia antibodies.
    Nyerges G
    Immunology; 1969 Sep; 17(3):333-7. PubMed ID: 5352004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring of human immunological responses to vaccinia virus.
    Harrop R; Ryan MG; Golding H; Redchenko I; Carroll MW
    Methods Mol Biol; 2004; 269():243-66. PubMed ID: 15114020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The hemagglutination inhibition test for rubella: a comparison of its sensitivity to that of neutralization, complement fixation and fluorescent antibody tests for diagnosis of infection and determination of immunity status.
    Lennette EH; Schmidt NJ; Magoffin RL
    J Immunol; 1967 Oct; 99(4):785-93. PubMed ID: 4860926
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of alveolar macrophages in inhalation infection of rabbits with vaccinia virus. I. Experiments with large doses of virus.
    Danes L; Benda R; Kruml J; Jelínková A
    Acta Virol; 1969 Nov; 13(6):521-6. PubMed ID: 4391719
    [No Abstract]   [Full Text] [Related]  

  • 20. Delayed hypersensitivity in vaccinia-infected mice. II. Resistance of peritoneal macrophages against vaccinia infection.
    Ueda S; Nozima T
    Acta Virol; 1973 Jan; 17(1):41-9. PubMed ID: 4405395
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.